Color company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

color.com

Founded Year

2013

Stage

Series E | Alive

Total Raised

$496.04M

Valuation

$0000 

Last Raised

$100M | 6 mos ago

About Color

Color democratizes access to genetic information. The Color Test is physician-ordered and comes with complimentary board-certified genetic counseling for clients and healthcare providers. The 30-gene Color Test analyzes genes closely associated with some of the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.

Color Headquarter Location

839 Mitten Rd Suite 100

Burlingame, California, 94010,

United States

650-544-9739

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Color

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Color is included in 10 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,113 items

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

M

Medical Devices

7,916 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,598 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

Color Patents

Color has filed 21 patents.

The 3 most popular patent topics include:

  • Data management
  • Bioinformatics
  • Blindness
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/12/2021

5/10/2022

Monoclonal antibodies, Blindness, Vision, Visual disturbances and blindness, Diseases of the eye and adnexa

Grant

Application Date

10/12/2021

Grant Date

5/10/2022

Title

Related Topics

Monoclonal antibodies, Blindness, Vision, Visual disturbances and blindness, Diseases of the eye and adnexa

Status

Grant

Latest Color News

08:15 EDT Global Home DNA Test Kit Market Report 2022-2028 Featuring 23andMe, Ancestry, Color Genomics, EasyDNA, Gene by Gene, I...

Apr 22, 2022

News provided by Share this article Share this article The global home genetic testing kit market is expected to surpass US$ 10 Billion by 2028 The report covers a detailed study of home genetic testing kit market size, growth and share, trends, consumption, segments, application, and forecast till 2028. In addition to this, the report also provides comprehensive analysis on the availability of home genetic testing kit across various geographical regions along with their commercial information. Home DNA Test Kit Market Opportunity Forecast 2028 Report Highlights: Global Home DNA Test Kit Market Opportunity > USD 10 Billion US Dominating Global DNA Test Kit Market > 20% Kits Availability & Price Analysis by Company, Country & Indication Global Home Genetic Testing Kit Market by Application: Ancestry, Nutrigenomics, Parenting, Chronic Diseases Global Home Genetic Testing Kit Market by Country: US, UK, china, India, Japan, South Korea, Taiwan, Singapore, Malaysia, Turkey, Russia, Canada, Middle East, Australia Global & Regional Market Forecast Till 2028 In last few decades, the field of genetics has witnessed rapid evolution which has eventually led to the development of genetic tests. In recent times, home genetic testing kits have entered the market which can be done at home without the prescription of healthcare professional. The introduction of home genetic testing kit has empowered people and gave them a feeling of personal control in improving the quality of their lives. It allows the rapid diagnosis of disorders when public or other private healthcare resources are in short supply. Till date, several home genetic testing kits have entered the global market which provides insights on various things including genetic disease risk analysis, personal wellbeing, ancestry, diet, nutrition, parenting, and others. One of the early players in home genetic testing kit market is 23andMe which has been known for its at-home DNA testing kit that only requires customers to mail in a little tube of saliva in order to gain useful insight into their genetic predispositions. Other private companies that are pushing the innovation edge and warrant watching include companies like Forward, which is a subscription-based service that combines DNA sequencing, AI, full-body scanning, and wearable's for mobile health monitoring along with instant access to medical care via smartphone app. The other key players in the market include Everlywell, Ancestry, MapmyGenome, EasyDNA, MedGenome, DNAwise, DNA labs, Genes2me, and others. Further, the arrival of COVID-19 pandemic has also pushed the home test kits market during the past two years. The rising COVID-19 cases globally have encouraged several pharmaceutical companies to develop cost-effective and easily available kit for diagnosis of the virus. In November 2020, Lucira COVID-19 All-In-One Test Kit was the first COVID-19 diagnostic kit for self-testing at home and that provides rapid results. More recently in October 2021, FDA issued EUA for the Acon Laboratories Flowflex COVID-19 home test, which is an over-the-counter antigen test. Cancer has a major impact on society across the world. It is one of the leading causes of death across the globe and is more prevalent in developed and emerging markets. On the basis of application, cancer diagnostic home genetic testing kits occupy the major share in the market. The rise in geriatric population and subsequent increase in the prevalence of cancer will drive the segment during the forthcoming years. In addition, initiatives by government and other organizations to spread cancer awareness and surge in number of home genetic cancer testing kits in developed countries will also boost the growth of market during forthcoming years. In last few years, there have been rising collaborations, partnerships, and strategic alliances among pharmaceutical companies in global home genetic testing kit market. For instance, Myriad Genetics announced strategic collaboration with Illumina for Illumina to create a kit based version of the myChoice diagnostic test for international markets. The agreement between the companies combines companion diagnostics and next generation sequencing to advance comprehensive genomic profiling of tumor samples and improved outcomes in oncology. In addition to this, South Korea's leading mobile carrier SK Telecom has collaborated with Macrogen to develop artificial intelligence backed genome analysis solution. Under this agreement, SK Telecom plans to set up system that analyzes, cumulates, and manages genomic data and medical information owned by Macrogen using artificial intelligence. Key Topics Covered: 1.1 Overview

Color Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Color Rank

  • When was Color founded?

    Color was founded in 2013.

  • Where is Color's headquarters?

    Color's headquarters is located at 839 Mitten Rd, Burlingame.

  • What is Color's latest funding round?

    Color's latest funding round is Series E.

  • How much did Color raise?

    Color raised a total of $496.04M.

  • Who are the investors of Color?

    Investors of Color include General Catalyst, Viking Global Investors, T. Rowe Price, Emerson Collective, Kindred Ventures and 22 more.

  • Who are Color's competitors?

    Competitors of Color include Nalagenetics, 23andMe, Helix, Cerner, Ginkgo Bioworks and 10 more.

You May Also Like

OmeCare Logo
OmeCare

OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.

PointCare Logo
PointCare

PointCare is making health coverage accessible and manageable for publicly covered patients. The company is establishing a coverage management system that allows Health Systems to simplify the enrollment cycle and retain coverage for their members.

Helix Logo
Helix

Helix connects people with the most fundamental aspect of what makes them unique: their own DNA. The company empowers consumers to discover and explore their own genomes through insights provided by its ecosystem of content partners.

S
Somos

Somos creates a genetic database for Latin Americans to track ethnic origins.

Solve.Care Logo
Solve.Care

Solve.Care was established to revolutionize healthcare delivery, care coordination and benefits administration around the globe. Solve.Care is building an platform that combines decentralization with synchronization to connect stakeholders with each other and redefine care, cost and convenience for everyone.

GeneproDX Logo
GeneproDX

Geneprodx is a clinical laboratory devoted to the molecular diagnostic of thyroid cancer. The company has developed ThyroidPrint, a molecular diagnostic test for thyroid cancer.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.